MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    How Botulinum Toxin Transformed the American Food Industry

    D. Riley (Cleveland Heights, USA)

    Objective: To highlight an episode of botulism that altered American food packaging technology Background: Early progress in understanding the behavior of botulinum toxin was marked…
  • 2024 International Congress

    Antibody-mediated movement disorders: a single-centre retrospective study

    J. Moura, S. Costa, I. Carrilho, S. Figueiroa, P. Carneiro, E. Neves, J. Damásio, E. Santos, R. Samões (Porto, Portugal)

    Objective: This study aims to evaluate the clinical spectrum of antibody-associated movement disorders from a single centre. Background: There is an increasing recognition of movement…
  • 2024 International Congress

    Tremors Vs. Tremors: the first music album from Parkinson’s tremors

    C. Dore, J. Thomas, S. Rose, J. Leitão, C. Hugill, C. Lambert (London, United Kingdom)

    Objective: Tremors Vs. Tremors is a creative engagement project exploring the intersection between music, mood and tremor. The objective was to raise awareness of Parkinson’s…
  • 2024 International Congress

    Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

    P. Singh, A. Gupta, A. Gupta (Delhi, India)

    Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…
  • 2024 International Congress

    Syllable-based speech characteristics as potential biomarker for differential diagnosis of Parkinson’s disease, multiple system atrophy, and cerebellar ataxia

    B. Jin, H. Kim, K. Woo, J. Shin (Seoul, Republic of Korea)

    Objective: To analyze syllable-based speech characteristics in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), and cerebellar ataxia (CA) to determine if there is…
  • 2024 International Congress

    Correlation of lmaging Markers with Clinical Features in Multiple System Atrophy Patients

    N. Jin (Hangzhou, China)

    Objective: This study aims to investigate the correlation between visually assessable imaging markers and their clinical symptoms in Multiple System Atrophy (MSA) patients. Background: MSA is…
  • 2024 International Congress

    Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.

    X. Li, FT. Liu (Shanghai, China)

    Objective: In this study, we aimed to investigate the frequency of Rapid eye movement sleep behavior disorder (RBD) occurring in a large cohort of PSP,…
  • 2024 International Congress

    Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

    N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)

    Objective: Assessment of the possible differences in peripheral inflammation severity between progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) with the use of three…
  • 2024 International Congress

    PSP: a Clinical Case

    K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)

    Objective: PSP is traditionally considered a neurodegenerative disease of late life. Its diagnostic criteria include the item “age of onset over 40 years.” This significantly…
  • 2024 International Congress

    α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease

    D. Coughlin, B. Shifflett, A. Siderowf, S. Edland, D. Galasko, C. Farris, Y. Ma, C. Soto, L. Concha-Marambio (San Diego, USA)

    Objective: To examine the relationship between the reaction parameters of the cerebrospinal fluid (CSF) αSyn seed amplification assay (αSyn-SAA) to the risk of developing motor…
  • « Previous Page
  • 1
  • …
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley